0

About Ebba Biotech

Ebba Biotech AB was founded in 2016 by professor Agneta Richter-Dahlfors to enable commercial applications and more widespread use of fluorescent tracer (optotracers) molecules, the result of many years of cutting-edge nanoscience and organic chemistry research. Ebba Biotech headoffice is based at Medeon (Science Park for Life Science in Malmö, Sweden) and professor Agneta Richter-Dahlfors has remains majority owner and chairman of the board. From the subsidiary located in Karolinska Institutet Science Park in Solna, Ebba Biotech produces, sells and delivers the many variants of purpose-built fluorescent tracer (optotracer) molecules to research laboratories, hospitals and industry worldwide.

“My passion has always been to make our nanoscience and organic chemistry research available to a wider audience. Finally, after spending years on research and development, we are ready and able to launch the full wavelength range of our fluorescent tracer (optotracer) molecule for probing and detecting bacterial biofilm.” says founder and chairman of Ebba Biotech AB, Professor Agneta Richter-Dahlfors.

info@ebbabiotech.com

About Ebba Biotech

Ebba Biotech Team

Susanne Löffler, Chief Technology Officer (CTO)

Susanne Löffler, PhD, Chief Technology Officer (CTO)

susanne.loffler@ebbabiotech.com

Susanne is appointed Chief Technology Officer (CTO) as part of our co-management team. She has been with Ebba Biotech since the beginning and co-authored publications detailing our optotracing technology

Susanne has held various roles throughout the years and will put her focus now of launching new products and applications for our products making use of the optotracing technology.


Smilla Huzell, Chief Operating Officer (COO)

Smilla Huzell, Chief Operating Officer (COO)

smilla.huzell@ebbabiotech.com | +46 70 721 23 77

Smilla is appointed Chief Operating Officer of Ebba Biotech. As part of the Ebba Biotech co-management team, it is her responsibility to make the company run smoothly and to reach our ambitious goals for the future by leading sales and day to day operations.

Smilla has been at Ebba Biotech since 2020 and has experience as a Research Engineer, Account Manager and Team Lead. She is a Biochemist by trade with a B.Sc. (Hons) from University of Glasgow and has hands-on experience with the optotracers as co-author of a milestone publication using EbbaBiolight for semi-automated visualisation of Salmonella biofilm.


Nora Herlin, Office & Marketing Coordinator

Nora Herlin, Office & Marketing Coordinator

nora.herlin@ebbabiotech.com | +46 73 985 40 51

Nora is our Customer Support specialist responsible for running daily operations at Ebba Biotech. She is the first point of contact for placing orders or reporting issues and handles the order logistics from preparation to delivery.


Emilie Falconer, Research Engineer

Emilie Falconer, Research Engineer

emilie.falconer@ebbabiotech.com | +46 73 560 56 30

Emilie is our Research Engineer handling the EbbaBiolight and Carbotrace product families. With her cross-disciplinary background in Microbiology and Molecular Biology coupled with her interest in Plant biotechnology, Emilie has an intricate understanding of how the optotracing technology is best utilised for various applications. Emilie has a background in Microbiology and Molecular Biology and graduated from Stockholm University with a Master’s degree in Biology. Her specialisation is in plant biology and aquatic ecosystems within microbiology.


Davide Trevisan, PhD, Product Manager

Davide Trevisan, PhD, Product Manager

davide.maria.trevisan@ebbabiotech.com | +46 73 745 69 93

Davide is our Product Manager with a specialisation for the Amytracker product series. He is the contact person for all inquiries regarding Amytracker as well as product quality assurance and general inquiries related to the laboratory in Solna.Davide carries a neuroscience background and extensive imaging experience collected during his PhD at the Karolinska Institute in Stockholm. Originally an intern in 2022, Davide returned in 2023 full time to further the Ebba Biotech product development and the optotracing technology.